Walter Hubsch

This inventor holds 58 USPTO granted patents, plus 6 CIPO patents, primarily in Pyridine Derivatives (CPC class 5143). Top assignees: Bayer Aktiengesellschaft, Bayer Intellectual Property Gmbh. Active years: 1990-2012.

USPTO Granted Patents = 58

% Patents Active = 96.6

CIPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 9.4

ph-index = 14

Forward Citations = 794(Granted Patents)

Forward Citations (Not Self Cited) = 769(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

57 out of 12,223

Bayer Aktiengesellschaft

patents

1 out of 721

Bayer Intellectual Property Gmbh

patents

Years Active: 1990-2012

Loading Chart...

Areas of Expertise:

Adenosine Receptor

Pyridine Derivatives

Heterocyclic Compounds

Trisubstituted Biphenyls

Imidazole Derivatives

Phenylacetamides

Sulphonylbenzyl Compounds

Cyclohexane Derivatives

Propenoic Acid Derivatives

Dicyano Compounds

Phenylacetic Acid Derivatives

Diaminoquinazolines

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8242281 - Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands (2012-08-14),

2. 7045631 - Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands (2006-05-16),

3. 5874438 - 2,2'-bridged bis-2,4-diaminoquinazolines (1999-02-23),

4. 5863930 - Trisubstituted biphenyls (1999-01-26),

5. 5861385 - Substituted triols (1999-01-19),

6. 5834481 - Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid (1998-11-10),

7. 5776964 - Heterocyclically substituted phenylacetic acid derivatives and their use (1998-07-07),

8. 5712296 - Substituted pyridines and 2-oxo-1,2-dihydropyridines (1998-01-27),

9. 5708003 - Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid (1998-01-13),

10. 5596006 - Trisubstituted biphenyls (1997-01-21),

11. 5530016 - Substituted 2,4-imidazolidinediones (1996-06-25),

12. 5527809 - Substituted imidazo[4,5-b]pyridines and benzimidazoles (1996-06-18),

13. 5521206 - Heterocyclically substituted phenylacetic acid derivatives and their use (1996-05-28),

14. 5508299 - Imidazolyl-substituted cyclohexane derivatives (1996-04-16),

15. 5492923 - Substituted pyridines and 2-oxo-1,2-dihydropyridines (1996-02-20),

Certainly! Here is an article about inventor Walter Hubsch:

Title: The Innovative Mind of Walter Hubsch: Pioneering Medicaments for Cardiovascular Disorders and Diabetes

Introduction:

In the realm of inventors, Walter Hubsch stands out as a visionary mind, hailing from Wuppertal, Germany. With a remarkable 58 patents under his belt, Walter's impact on the fields of pharmaceuticals and medicaments is truly extraordinary.

Latest Patents:

Walter's recent patent inventions include the development of Substituted 2,6-diamino-3,5-dicyano-4-arylpyridines and Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines. These innovations serve as adenosine-receptor-selective ligands, offering promising prospects for the treatment of cardiovascular disorders and diabetes.

Career Highlights:

Throughout his career, Walter Hubsch has made significant contributions while working at renowned companies such as Bayer AG (formerly Bayer Aktiengesellschaft) and Bayer Intellectual Property GmbH. His innovative spirit and dedication have left a lasting impact on the pharmaceutical industry.

Collaborations:

In his journey of innovation, Walter collaborated with esteemed colleagues like Peter Fey and Hilmar Bischoff. Together, they have pushed the boundaries of pharmaceutical research, paving the way for groundbreaking discoveries in medicament development.

Conclusion:

In conclusion, Walter Hubsch's inventive prowess and tireless commitment to advancing healthcare solutions have solidified his legacy as a trailblazing inventor. His patents and collaborative efforts underscore his invaluable contributions to the field, inspiring future generations of inventors to push the boundaries of innovation even further.